Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection	AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Active, not recruiting	Phase 2	2025-04-13		NCT04505501

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Henry M. Jackson Foundation for the Advancement of Military Medicine	35
Thai Red Cross AIDS Research Centre	7
Walter Reed Army Institute of Research (WRAIR)	16

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Thai Red Cross AIDS Research Centre	Bangkok	Thailand	1